|
G |
Ahr |
aryl hydrocarbon receptor |
increases activity affects binding |
EXP |
laquinimod analog results in increased activity of AHR protein laquinimod analog binds to AHR protein |
CTD |
PMID:28433708 PMID:29908305 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ahrr |
aryl-hydrocarbon receptor repressor |
increases expression |
EXP |
laquinimod analog results in increased expression of AHRR mRNA |
CTD |
PMID:28433708 |
|
NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression multiple interactions |
EXP ISO |
laquinimod analog results in increased expression of CYP1A1 mRNA; laquinimod analog results in increased expression of CYP1A1 protein; laquinimod metabolite results in increased expression of CYP1A1 mRNA; laquinimod metabolite results in increased expression of CYP1A1 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [laquinimod analog results in increased expression of CYP1A1 protein] |
CTD |
PMID:28433708 PMID:29908305 PMID:32668270 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
EXP |
laquinimod analog results in increased expression of CYP1A2 mRNA |
CTD |
PMID:28433708 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression multiple interactions |
EXP ISO |
laquinimod analog results in increased expression of CYP1B1 mRNA; laquinimod metabolite results in increased expression of CYP1B1 mRNA Progesterone promotes the reaction [laquinimod metabolite results in increased expression of CYP1B1 mRNA] |
CTD |
PMID:28433708 PMID:32668270 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions increases metabolic processing |
ISO |
Ketoconazole inhibits the reaction [CYP3A4 protein results in increased metabolism of laquinimod]; Troleandomycin inhibits the reaction [CYP3A4 protein results in increased metabolism of laquinimod] |
CTD |
PMID:15764719 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
EXP |
laquinimod analog results in increased expression of NQO1 mRNA |
CTD |
PMID:28433708 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|